Emery, Christopher
577  results:
Search for persons X
?
8

Ceftolozane-tazobactam and ceftazidime-avibactam activity a..:

Hirsch, Elizabeth B. ; Brigman, Hunter V. ; Zucchi, Paola C....
Journal of Global Antimicrobial Resistance.  22 (2020)  - p. 689-694 , 2020
 
?
9

2164. Activity of Fosfomycin (FOF) and Frequency of Nonsusc..:

Smith, Elizabeth C ; Brigman, Hunter V ; Anderson, Jadyn C...
Open Forum Infectious Diseases.  6 (2019)  Supplement_2 - p. S734-S734 , 2019
 
?
10

Susceptibility Provision Enhances Effective De-escalation (..:

Schneider, Jack G ; Wood, James B ; Schmitt, Bryan H...
Journal of Antimicrobial Chemotherapy.  74 (2019)  Supplement_1 - p. i16-i23 , 2019
 
?
 
?
12

Direct antimicrobial susceptibility testing of positive blo..:

Schneider, Jack G. ; Wood, James B. ; Smith, Nathan W....
Diagnostic Microbiology and Infectious Disease.  95 (2019)  3 - p. 114841 , 2019
 
?
13

Comparison of 4 commercially available group BStreptococcus..:

Relich, Ryan F. ; Buckner, Rebecca J. ; Emery, Christopher L..
Diagnostic Microbiology and Infectious Disease.  91 (2018)  4 - p. 305-308 , 2018
 
?
14

1986. Rapid Identification and Antimicrobial Susceptibility..:

Schneider, Jack ; Wood, James ; Schmitt, Bryan...
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S577-S577 , 2018
 
?
15

Activity of Ceftolozane/tazobactam (C/T) and Ceftazidime/av..:

Hirsch, Elizabeth B ; Zucchi, Paola ; Cheung, Nicole...
Open Forum Infectious Diseases.  4 (2017)  suppl_1 - p. S376-S376 , 2017
 
1-15